Research Article
The Markers of Glutamate Metabolism in Peripheral Blood Mononuclear Cells and Neurological Complications in Lung Cancer Patients
Table 2
The concentration of glutamate and activities of GLS, GDH, and GAD in sera of lung cancer patients during chemotherapy.
.
| | Baseline | After 6-month chemotherapy |
| Glutamate (μmol/L) median; minimum–maximum | 412.83 85.41–5456.27 | 3971.83 399.74–4937.04 |
| Glutaminase (mU/L) median; minimum–maximum | 1.66 0–3.02 | 0.63 0.33–2.61 |
| Glutamate dehydrogenase (mU/mL) median; minimum–maximum | 89.81 25.73–154.88 | 105.78 66.60–134.65 |
| Glutamate decarboxylase (U/L) median; minimum–maximum | 405.06 0–1589.09 | 611.49 210.32–903.60 |
|
|